| European Case Law Identifier: | ECLI:EP:BA:2013:T213410.20131114 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 14 November 2013 | ||||||||
| Case number: | T 2134/10 | ||||||||
| Application number: | 97946850.1 | ||||||||
| IPC class: | C12N 15/31 C07K 14/315 G01N 33/569 G01N 33/68 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | STREPTOCOCCUS PNEUMONIAE ANTIGENS AND VACCINES | ||||||||
| Applicant name: | HUMAN GENOME SCIENCES, INC. | ||||||||
| Opponent name: | Sanofi Pasteur Limited | ||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main Request: requirements of the EPC met (yes) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t102134eu1.html
Date retrieved: 17 May 2021